REGISTRATION & Networking Breakfast
8:30 - 8:35
Perry Niro, President, Pharmed Canada & Anie Perrault, Executive Director, BIOQuébec
8:35 - 9:30
Stock Exchange & Public Market: is the window opening ?
Moderator: Lolita Guerrera, Associate Vice-Presidente, RBC Royal Bank
Market Review in Life Sciences
Douglas Miehm, Managing Director, Global Research, Healthcare, RBC Capital Markets, Toronto
My $ 100 M IPO on NASDAQ
Michael Singer, CFO, CLÉMENTIA
9:30 - 10:15
MEDTECH & Artificial Intelligence
Investors & Entrepreneurs points of view of Artificial Intelligence is impacting Life Sciences
Moderator: Benoit Larose, Vice-President Quebec, MEDEC
Katherine Parra Moreno, VP Medtech/Digital Health, Venture Capital, Epic Capital Management
Alexandre Le Bouthiller, President & Founder, IMAGIA Cybernetics
Louise Beauchesne, Executive Regional Director, Quebec & Atlantic, IBM Canada
10:15 - 10:30
10:30 - 12:00
Dragon Den's Start-Up Pitch
New this year, four companies will be invited to make a 5 minutes pitch to our panels of investors. The panelists will be invited to comment on the presentation, give some advice and share some insight.
Following these presentations, participants will be invited to vote on the best presentation.
Moderated by Perry Niro, President of Pharma Canada and Tuba Yamac, Senior Patent Agent at BCF LLP.
The winner will receive a package of professional services from BCF.
The participants for this year's Dragon Den are
Simon Sanscartier, CFO, MYOVUE
Bernard Fortier, CEO, Tetra Bio-Pharma
Véronique Bougie, CEO, Corbin Therapeutics
Francois-Thomas Michaud, CEO, Feldan Therapeutics
This year's Dragons are:
Michael Lincoln, Chief Financial and Business Officer, Accel-Rx Health Sciences Fund (Vancouver)
Jean-François Pariseau, Partner, Healthcare Fund, BDC Capital (Montreal)
Nicola Urbani, Investment Director, Emerillon Capital (Montreal)
Paulina S. Hill, Principal, Polaris Partners (Boston)
Lidija Marusic, Investment Manager, Innovacorp (Halifax)
12:00 - 13:30
Moderator: Anie Perrault,
Executive Director, BIOQuébec
Ernst & Young 2017 Report
Staying the Course
Lara Iob, CPA, Partner, EY Canada
Yann Lavallée, Partner, EY Canada
13:30 - 15:00
Co-Development & Alternatives Funding Opportunities
AstraZeneca's Open Innovation Program
The Open Innovation platform provides an open, collaborative approach to link AstraZeneca's expertise, unique research tools, optimised molecules, technologies and challenges with start-ups research capabilities and interests. Come learn how you can work together with AZ to accelerate the advancement of medical science and bring novel therapies to patients.
Pamela Hill, Associate director, Open Innovation Program Manager, AstraZeneca
CF Foundation Venture Philanthropy Model
Through its venture philanthropy model, the Cystic Fibrosis Foundation provides early stage funding to biotechnology and pharmaceutical companies to develop breakthrough drugs for adults and children with cystic fibrosis. Presentation on the model, and some ideas on how to extend it to other organizations.
John Wallenburg, Chief Scientific Officer, Cystic Fibrosis Canada
Business Tax Incentives for start-ups
Business tax incentives and government grants constitute a lucrative source of funding for start-up companies based in Quebec and Canada. As a Life Science start-up company, find out how to use Canadian and Quebec financial incentives and grants to allow you to grow your company, innovate and advance in your field!
Soraya Khouadri, Manager, SR&ED & BTI services, EY Canada
Legal & IP Start-Up Program
BCF is proud to contribute to the success of Quebec startups, as well as entrepreneurs that will become the leaders of tomorrow’s economy. With BCF Imagine, we are offering a complete range of legal services and business coaching, all the while keeping your specific needs in mind. Our objective is to assure that your business reaches its full potential. We will ensure that your technological business is protected and properly valued, so that you can focus on changing the world in your own way.
- Me Brigitte Nepveu, Partner, Lawyer, & Andréanne Auger, Senior Patent Agent, BCF Business Law
Closing & B2B Meetings